Katja Weisel, MD of Janssen Oncology discusses the impact of the POLLUX and CASTOR trial on clinical practice, which are both already introduced in daily practice. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.
Katja Weisel, MD of Janssen Oncology discusses the impact of the POLLUX and CASTOR trial on clinical practice, which are both already introduced in daily practice. This was recorded at the 2017 ASCO Annual Meeting in Chicago, IL.